Actively Recruiting
Diurnal Blood Pressure and Arterial Stiffness Patterns in Those at Increased Risk of Cardiovascular Disease
Led by University of Edinburgh · Updated on 2025-09-23
120
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying blood pressure and arterial stiffness patterns over 24 hours in people at increased risk of cardiovascular disease (CVD), including those with kidney conditions such as acute kidney injury, chronic kidney disease, small vessel vasculitis, kidney transplant recipients, and donors. The study aims to understand how natural nighttime drops in blood pressure and arterial stiffness, which protect against CVD, vary in these groups compared to healthy individuals. This research is important because abnormal daily patterns may increase CVD risk and need better characterization to improve treatments. Participants will undergo 24-hour monitoring of blood pressure and arterial stiffness using a Mobil-o-graph device on two separate occasions. Blood and urine samples will also be collected during day and night periods to measure specific markers. The study includes six groups: healthy controls and five patient groups with different kidney-related conditions. This observational study does not involve treatment but focuses on detailed assessment of cardiovascular risk factors. During the study, participants will have ambulatory blood pressure and arterial stiffness measurements alongside scheduled blood and urine tests. Researchers will evaluate nighttime blood pressure and arterial stiffness dips as primary outcomes, as well as changes in specific urine and plasma markers. The study is sponsored by the University of Edinburgh and aims to provide data that may guide targeted cardiovascular risk reduction. Participants will be followed until the study ends in 2026, with visits occurring on two occasions for the assessments.
CONDITIONS
Brief Title
Diurnal BP Patterns in Those at Increased Risk of CVD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 90 years
- Patients attending NHS Lothian inpatient or outpatient services at increased risk of cardiovascular disease
- Diagnosis including chronic kidney disease, acute kidney injury, small vessel vasculitis, kidney transplant recipient, or kidney donor
- Healthy individuals with no known medical condition and taking no regular medication
- Ability to provide informed consent
You will not qualify if you...
- Age less than 18 years or greater than 90 years
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo assessment of 24-hour blood pressure and arterial stiffness using a Mobil-o-graph device.
1 visit (in-person)
Duration - Up to several days around the diagnostic assessment
Participants are monitored for changes in urine and plasma ET-1 concentrations measured in the morning and evening.
1 to 2 visits depending on sample collection timing
Trial Site Locations
Total: 1 location
1
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom, EH164SA
Actively Recruiting
Research Team
N
Neeraj Dhaun, MBChB PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here